Research ArticleOriginal Article

A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma

Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397

Article Information

vol. 18 no. 3 734-749
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2020.0397
Published By 
Cancer Biology & Medicine
History 
  • Received July 25, 2020
  • Accepted October 27, 2020
  • Published online August 1, 2021.
Copyright & Usage 
Copyright: © 2021, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Chengming Liu1,
  2. Sihui Wang1,
  3. Sufei Zheng1,
  4. Xinfeng Wang1,
  5. Jianbin Huang1,
  6. Yuanyuan Lei1,
  7. Shuangshuang Mao1,
  8. Xiaoli Feng2,
  9. Nan Sun1⇑ and
  10. Jie He1⇑
  1. 1Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  2. 2Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  1. Correspondence to: Jie He and Nan Sun, E-mail: prof.jiehe{at}gmail.com and sunnan{at}vip.126.com
View Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords